2020
DOI: 10.1371/journal.pone.0233886
|View full text |Cite
|
Sign up to set email alerts
|

The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer’s diseases— A simulation study combining multi-center data and ADNI-data

Abstract: Background The purpose of this study was to assess the impact of vendor-provided atlas-based MRAC on FDG PET/MR for the evaluation of Alzheimer's disease (AD) by using simulated images. Methods We recruited 47 patients, from two institutions, who underwent PET/CT and PET/MR (GE SIGNA) examination for oncological staging. From the PET raw data acquired on PET/MR, two FDG-PET series were generated, using vendor-provided MRAC (atlas-based) and CTAC. The following simulation steps were performed in MNI space: Afte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 34 publications
0
7
0
Order By: Relevance
“…From ADNI-1 data, we extracted 107 participants (48 healthy and 59 AD participants). The inclusion criteria were completeness of date of birth and diagnosis (healthy or AD) who visit 24 months after 1st PET scan, which inclusion criteria was the same as our previous simulation study focusing on Atlas-based MRAC (Sekine et al, 2020). All raw PET images were of sufficient quality for visual scoring and for softwarebased analysis using PALZ (PMOD Alzheimer's Discrimination tool, Zurich, Switzerland).…”
Section: Alzheimer Disease Neuroimaging Initiative (Adni) Datamentioning
confidence: 99%
See 4 more Smart Citations
“…From ADNI-1 data, we extracted 107 participants (48 healthy and 59 AD participants). The inclusion criteria were completeness of date of birth and diagnosis (healthy or AD) who visit 24 months after 1st PET scan, which inclusion criteria was the same as our previous simulation study focusing on Atlas-based MRAC (Sekine et al, 2020). All raw PET images were of sufficient quality for visual scoring and for softwarebased analysis using PALZ (PMOD Alzheimer's Discrimination tool, Zurich, Switzerland).…”
Section: Alzheimer Disease Neuroimaging Initiative (Adni) Datamentioning
confidence: 99%
“…We recruited 27 patients who underwent both PET/CT and PET/MR for oncologic staging from our previous study (Delso et al, 2018;Sekine et al, 2020). The 27 patients (15 males and 12 females, 60.0 ± 13.0 years) with lymphoma, pheochromocytoma, myeloma, melanoma, Merkel-cell cancer, lung cancer, pancreatic cancer, breast cancer and dementia were collected from another previous study, after excluding 3 patients.…”
Section: Patientsmentioning
confidence: 99%
See 3 more Smart Citations